Does dupilumab treatment treat prurigo nodularis?

Prurigo nodularis causes intensely itchy, firm nodules that can be maintained by repeated scratching or rubbing. Dupilumab is a targeted biologic medicine that changes specific inflammatory signals involved in itch and skin inflammation. A clinician may consider it when the condition is persistent or has not responded adequately to other care. The diagnosis, severity, previous treatment, and general health all shape the decision.

The nodules and itch may not change at the same pace. Skin protection, moisturising, prescribed topical treatment, and strategies to reduce scratching can remain useful alongside an injectable medicine. Keep follow-up appointments so the response and tolerability can be assessed.

Tell the dermatologist about current medicines, allergies, eye symptoms, infections, and any condition affecting your immune system. Use dupilumab exactly as prescribed and do not share, double, or stop doses without advice. Keep nails short, cover areas that are scratched during sleep if appropriate, and use the recommended moisturiser or topical treatment to protect the skin.

Contact your care team if nodules become increasingly painful, warm, swollen, or drain fluid, or if itching is preventing sleep despite treatment. Report new eye irritation, eye pain, vision changes, or signs of infection. Seek emergency help for facial or tongue swelling, trouble breathing, or faintness after an injection.

Ask whether your nodules and itch fit prurigo nodularis, why dupilumab is suitable, and how progress will be judged. Ask which creams or itch-control measures continue during treatment, what to do after a missed dose, and which symptoms require urgent assessment.